NARA MEDICAL UNIVERSITY

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: Private

Established: 1945-01-01

Employees: -

Market Cap: -

Website: http://www.naramed-u.ac.jp

Clinical Trials

Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors

Conditions: Hemophilia A With Inhibitor

First Posted Date: 2015-09-18

Last Posted Date: 2015-09-18

Lead Sponsor: Nara Medical University

Target Recruit Count: 10

Registration Number: NCT02554526

Locations: 🇯🇵
Department of Pediatrics, Kashihara, Nara, Japan

New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering

Phase 4

Completed

Conditions: Hypertension

Interventions: Drug: Valsartan
Drug: Azilsartan

First Posted Date: 2012-06-01

Last Posted Date: 2013-10-30

Lead Sponsor: Nara Medical University

Target Recruit Count: 70

Registration Number: NCT01609959

Locations: 🇯🇵
First Department of Nara Medical University, Kashihara, Nara, Japan

The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure

Phase 4

Terminated

Conditions: Heart Failure
Renal Failure

Interventions: Drug: Standard heart failure therapy
Drug: Carperitide heart failure therapy

First Posted Date: 2008-02-13

Last Posted Date: 2011-07-22

Lead Sponsor: Nara Medical University

Target Recruit Count: 200

Registration Number: NCT00613964

Locations: 🇯🇵
First Department of Internal Medicine, Nara Medical University, Nara, Japan

Hemofiltration for Contrast-Induced Nephropathy

Not Applicable

Conditions: Chronic Kidney Disease
Cardiac Catheterization

First Posted Date: 2005-09-12

Last Posted Date: 2005-09-12

Lead Sponsor: Nara Medical University

Target Recruit Count: 100

Registration Number: NCT00158080

Locations: 🇯🇵
First Dept of InternalMedicine, Nara Medical University, Kashihara, Nara, Japan

Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline

Phase 4

Completed

Conditions: Brain Infarction
Hypertension

Interventions: Drug: Angiotensin II Receptor Antagonists
Drug: Angiotensin-converting Enzyme Inhibitors

First Posted Date: 2005-08-04

Last Posted Date: 2013-10-30

Lead Sponsor: Nara Medical University

Target Recruit Count: 395

Registration Number: NCT00126516

Locations: 🇯🇵
First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy